Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
This trial studies the impact of the breast cancer pathways program on the patient experience, including decision making and quality of life. Measuring how the breast cancer pathways program affects decision making and quality of life in patients may help doctors improve cancer education.
Anatomic Stage IV Breast Cancer AJCC v8|Breast Carcinoma|Metastatic Breast Carcinoma|Prognostic Stage IV Breast Cancer AJCC v8|Recurrent Breast Carcinoma
OTHER: Informational Intervention|OTHER: Informational Intervention|OTHER: Quality-of-Life Assessment|OTHER: Survey Administration
change in Patient quality of life, Assessed by surveys., Baseline and 8 weeks|Change in Patient quality of decision, Assessed by surveys, Baseline and 8 weeks|Number of physician visits and diagnostic tests, Up to 2 years
PRIMARY OBJECTIVES:

I. Evaluate the impact of breast cancer pathways on patient experience, burden of decision making and quality of life in tertiary cancer center and community oncology practice.

II. Identify modifiable factors that affect provider adoption of breast cancer pathways in tertiary cancer center and community oncology practice.

OUTLINE: Participants are assigned to 1 of 2 groups.

GROUP I: Participants receive standard chemotherapy educational materials. Participants also complete surveys over approximately 22 minutes at the time of first chemotherapy infusion, and approximately 8 weeks after first chemotherapy infusion.

GROUP II: Participants receive personalized information about their cancer, treatment, and side effects. Participants also complete surveys over approximately 22 minutes at the time of first chemotherapy infusion, and approximately 8 weeks after first chemotherapy infusion.